ATE17574T1 - Zwischenprodukte zur herstellung von thienamycin und verfahren zu ihrer herstellung. - Google Patents

Zwischenprodukte zur herstellung von thienamycin und verfahren zu ihrer herstellung.

Info

Publication number
ATE17574T1
ATE17574T1 AT82105683T AT82105683T ATE17574T1 AT E17574 T1 ATE17574 T1 AT E17574T1 AT 82105683 T AT82105683 T AT 82105683T AT 82105683 T AT82105683 T AT 82105683T AT E17574 T1 ATE17574 T1 AT E17574T1
Authority
AT
Austria
Prior art keywords
manufacture
chem
hydrogen
thienamycin
protecting group
Prior art date
Application number
AT82105683T
Other languages
English (en)
Inventor
Burton Grant Christensen
Thomas Norse Salzmann
Ronald William Ratcliffe
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/933,323 external-priority patent/US4174316A/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE17574T1 publication Critical patent/ATE17574T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02—Preparation
    • C07D477/04—Preparation by forming the ring or condensed ring systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
AT82105683T 1978-08-14 1979-05-01 Zwischenprodukte zur herstellung von thienamycin und verfahren zu ihrer herstellung. ATE17574T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/933,323 US4174316A (en) 1978-08-14 1978-08-14 4-Iodomethylazetidin-2-one
EP79101307A EP0007973B1 (de) 1978-08-14 1979-05-01 Verfahren zur Herstellung von Thienamycin und Zwischenprodukten

Publications (1)

Publication Number Publication Date
ATE17574T1 true ATE17574T1 (de) 1986-02-15

Family

ID=26077680

Family Applications (2)

Application Number Title Priority Date Filing Date
AT82105683T ATE17574T1 (de) 1978-08-14 1979-05-01 Zwischenprodukte zur herstellung von thienamycin und verfahren zu ihrer herstellung.
AT79101307T ATE6065T1 (de) 1978-08-14 1979-05-01 Verfahren zur herstellung von thienamycin und zwischenprodukten.

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT79101307T ATE6065T1 (de) 1978-08-14 1979-05-01 Verfahren zur herstellung von thienamycin und zwischenprodukten.

Country Status (3)

Country Link
EP (1) EP0066301B1 (de)
AT (2) ATE17574T1 (de)
DE (1) DE2967572D1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6253994A (ja) 1985-05-09 1987-03-09 Yamanouchi Pharmaceut Co Ltd １−置換シリル−４−オキソ−２−アゼチジンカルボン酸低級アルキルエステル

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4122086A (en) * 1977-07-26 1978-10-24 Smithkline Corporation Isopenicillins

Also Published As

Publication number Publication date
ATE6065T1 (de) 1984-02-15
DE2967572D1 (en) 1986-03-06
EP0066301B1 (de) 1986-01-22
EP0066301A1 (de) 1982-12-08

Similar Documents

Publication Publication Date Title
ATE87925T1 (de) Erythromycin-a-derivate und verfahren zu ihrer herstellung.
ATE58896T1 (de) Neue zwischenprodukte und verfahren zur herstellung von 3-acylamino-1-hydroxy-2azetidinonen.
ATE60060T1 (de) Sialosylceramide und verfahren zu deren herstellung.
ATE35417T1 (de) Verfahren zur herstellung von phosphorhaltigen cyanhydrinderivaten.
ATE10372T1 (de) Synisomer von cephalosporinverbindungen und verfahren zu ihrer herstellung.
ATE17574T1 (de) Zwischenprodukte zur herstellung von thienamycin und verfahren zu ihrer herstellung.
PT79118B (de) Cephalosporinderivate und verfahren zur ihrer herstellung
ATE34977T1 (de) Verfahren zur herstellung von cholecalciferolderivaten.
ATE17486T1 (de) Verfahren zur herstellung von chinolinen, zwischenprodukten und verfahren zu ihrer herstellung.
ATE5077T1 (de) 22-arylsulfonyl-24,25-dihydroxy-cholestane und verfahren zu ihrer herstellung.
DE69332707D1 (de) Verfahren zur Herstellung von 3-Vinylcephalosporinen
ATE18901T1 (de) Zwischenprodukte zur herstellung von 4-phenyl-1,3-benzodiazepinen und verfahren zur herstellung dieser zwischenprodukte.
ATE9223T1 (de) Keten-o,n-acetale, verfahren zu ihrer herstellung, diese enthaltende fungizide und ihre verwendung zur bekaempfung von pilzen.
DE3473269D1 (en) (bis(substituted methyl)-methyl)-isoquinoline derivatives, process for their preparation and pharmaceutical compositions containing them
ATE1816T1 (de) Pyrazolin-5-on-yl-methyl(di)thiophosphors[ureester, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung von schaedlingen.
SE7503560L (de)
ATE5410T1 (de) N-methyl-n-silyl-carbamate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung von schaedlingen.
ATE135693T1 (de) Halogeno-4-methylpyrazole und verfahren zu ihrer herstellung
ATE142637T1 (de) Neues verfahren zur herstellung von 20-oxo, 17- alpha, 21-dihydroxy derivaten von pregnan und neue zwischenprodukte dafür
ATE159939T1 (de) Verfahren und zwischenprodukte für die herstellung von 6-fluorbenzisothiazolen
ATE27281T1 (de) Verfahren zur herstellung von oxanosin.
ATE92481T1 (de) Verfahren zur herstellung von n,n'-bis-(2hydroxyethyl)-piperazin.
ATE967T1 (de) Verfahren zur herstellung von xanthonderivaten.
ATE18194T1 (de) Verfahren zur herstellung von carbonsaeureanhydriden.
ATE39688T1 (de) Verfahren zur herstellung von aminotriazinonderivaten.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification